1-3 of 3
David B. Agus
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines

Kian Kani, Carolina Garri, Katrin Tiemann, Paymaneh D. Malihi, Vasu Punj, Anthony L. Nguyen, Janet Lee, Lindsey D. Hughes, Ruth M. Alvarez, Damien M. Wood, Ah Young Joo, Jonathan E. Katz, David B. Agus, Parag Mallick
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2017) 16 (8): 1645–1657.
https://doi.org/10.1158/1535-7163.MCT-16-0564
Published: 02 August 2017
View article titled, JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines
Open the PDF for JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines in another window
Includes: Supplementary data
Journal Articles

Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition

Kian Kani, Vitor M. Faca, Lindsey D. Hughes, Wenxuan Zhang, Qiaojun Fang, Babak Shahbaba, Roland Luethy, Jonathan Erde, Joanna Schmidt, Sharon J. Pitteri, Qing Zhang, Jonathan E. Katz, Mitchell E. Gross, Sylvia K. Plevritis, Martin W. McIntosh, Anjali Jain, Samir Hanash, David B. Agus, Parag Mallick
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2012) 11 (5): 1071–1081.
https://doi.org/10.1158/1535-7163.MCT-11-0852
Published: 08 May 2012
View article titled, Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition
Open the PDF for Quantitative Proteomic Profiling Identifies Protein Correlates to EGFR Kinase Inhibition in another window
Includes: Supplementary data
Journal Articles

Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes

Shannon M. Mumenthaler, Patricia Y.B. Ng, Amanda Hodge, David Bearss, Gregory Berk, Sarath Kanekal, Sanjeev Redkar, Pietro Taverna, David B. Agus, Anjali Jain
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (10): 2882–2893.
https://doi.org/10.1158/1535-7163.MCT-09-0293
Published: 12 October 2009
View article titled, Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes
Open the PDF for Pharmacologic inhibition of Pim kinases alters prostate cancer cell growth and resensitizes chemoresistant cells to taxanes in another window